Skip to content

Advertisement

BMC Musculoskeletal Disorders

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: results from a randomized double blind controlled clinical trial

  • Harindu Wijesinghe1,
  • Priyadharshini Galappatthy2, 10Email author,
  • Rajiva de Silva3,
  • Suranjith L. Seneviratne4, 5,
  • Ushagowry Saravanamuttu1,
  • Preethi Udagama6,
  • Melanie Hart7,
  • Peter Kelleher7,
  • Upul Senerath8,
  • Rohini Fernandopulle9,
  • Lilani P. Weerasekera1 and
  • Lalith S. Wijayaratne1
BMC Musculoskeletal DisordersBMC series – open, inclusive and trusted201718:310

https://doi.org/10.1186/s12891-017-1673-3

Received: 29 November 2016

Accepted: 13 July 2017

Published: 19 July 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
29 Nov 2016 Submitted Original manuscript
30 Jan 2017 Reviewed Reviewer Report - Johannes Nossent
3 Mar 2017 Reviewed Reviewer Report - William Rigby
26 Mar 2017 Author responded Author comments - Harindu Wijesinghe
Resubmission - Version 2
26 Mar 2017 Submitted Manuscript version 2
30 Mar 2017 Reviewed Reviewer Report - Johannes Nossent
24 Apr 2017 Reviewed Reviewer Report - William Rigby
21 May 2017 Author responded Author comments - Harindu Wijesinghe
Resubmission - Version 3
21 May 2017 Submitted Manuscript version 3
25 May 2017 Reviewed Reviewer Report - Johannes Nossent
17 Jun 2017 Author responded Author comments - Harindu Wijesinghe
Resubmission - Version 4
17 Jun 2017 Submitted Manuscript version 4
Publishing
13 Jul 2017 Editorially accepted
19 Jul 2017 Article published 10.1186/s12891-017-1673-3

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Rheumatology, The National Hospital of Sri Lanka
(2)
Department of Pharmacology, Faculty of Medicine, University of Colombo
(3)
Department of immunology, Medical Research Institute
(4)
Consultant and Professor in Clinical Immunology and Allergy, Royal Free Hospital, University College London
(5)
Department of Surgery, Faculty of Medicine, University of Colombo
(6)
Department of Zoology, Faculty of Science, University of Colombo
(7)
Immunology Section Imperial College, and Department of Infection & Immunity
(8)
Department of Community Medicine, Faculty of Medicine, University of Colombo
(9)
Department of Pharmacology, General Sir John Kotelawala Defense University
(10)
Department of Pharmacology and Pharmacy, Faculty of Medicine, University of Colombo

Advertisement